Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-23

Clinical Trial Update: PET Imaging and Olanzapine Treatment in Borderline Personality Disorder [NA]

View source ↗

Summary

This clinical trial update reports on PET imaging and olanzapine treatment in Borderline Personality Disorder, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: University of Minnesota | Conditions: Borderline Personality Disorder | NA | Status: COMPLETED | Results posted: 2017-05-23